Simpson Thacher represented the underwriters, led by Goldman, Sachs & Co., Citigroup Global Markets Inc., Deutsche Bank Securities Inc. and J.P. Morgan Securities LLC, in a...
You must be a Standard 1 Year member to access this content.
Davis Polk advised Texas Instruments Incorporated on its SEC-registered debt offering of $200 million aggregate principal amount of 4.150% notes due 2048. The 4.150% notes due...
You must be a Standard 1 Year member to access this content.
Simpson Thacher represented Hilton Worldwide Holdings Inc. (NYSE: HLT) in connection with secondary sales of 15,800,000 shares of common stock by certain selling stockholders affiliated with...
You must be a Standard 1 Year member to access this content.
Davis Polk advised DXC Technology Company in connection with a €400 million unsecured term loan facility. The term loan is scheduled to mature on May 10,...
You must be a Standard 1 Year member to access this content.
Winston & Strawn, Carey, Cravath, Swaine & Moore and Alessandri advised on the deal Enel Chile S.A. executed a $1 billion registered notes offering. Enel Chile...
You must be a Standard 1 Year member to access this content.
Davis Polk advised Israel Chemicals Limited in connection with its 144A/Regulation S notes offering of $600 million aggregate principal amount of 6.375% senior notes due 2038....
You must be a Standard 1 Year member to access this content.
J.P. Morgan Securities LLC is acting as exclusive financial advisor to Rent-A-Center and provided a fairness opinion to the Rent-A-Center Board of Directors. Winston & Strawn...
You must be a Standard 1 Year member to access this content.
Davis Polk advised the representatives of the several underwriters in connection with Iterum Therapeutics plc’s initial public offering of 6,150,000 ordinary shares, at $13.00 per share,...
You must be a Standard 1 Year member to access this content.
Davis Polk advised the sole placement agent in connection with the private exchange of an aggregate of approximately $193 million of Pandora Media, Inc.’s 1.75% convertible...
You must be a Standard 1 Year member to access this content.
Davis Polk advised Valeant Pharmaceuticals International, Inc. in connection with a refinancing transaction pursuant to which its indirect wholly owned subsidiary, Valeant Pharmaceuticals International, issued new...
You must be a Standard 1 Year member to access this content.
Davis Polk advised the joint book-running managers on an SEC-registered offering by Valero Energy Corporation of $750 million aggregate principal amount of its 4.350% senior notes...
You must be a Standard 1 Year member to access this content.
Goodwin advised Onxeo S.A. on the deal Onxeo S.A. (Euronext Paris, NASDAQ Copenhagen: ONXEO) in its royalty and milestone monetization financing with SWK Holdings Corporation. Through...
You must be a Standard 1 Year member to access this content.
